Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 Return-on-Tangible-Asset is 21.42% as of Mar. 2026, which is 21% above its 10-year median of 17.69. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 685 Healthcare Providers & Services companies, Pramodini Medicare ranks better than 66.72% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Pramodini Medicare's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹192.3 Mil. Pramodini Medicare's average total tangible assets for the quarter that ended in Mar. 2026 was ₹897.9 Mil. Therefore, Pramodini Medicare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 21.42%.
The historical rank and industry rank for Pramodini Medicare's Return-on-Tangible-Asset or its related term are showing as below:
NSE:PRAMODINI'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.11 Med: 17.69 Max: 23.16
Current: 6.11
During the past 4 years, Pramodini Medicare's highest Return-on-Tangible-Asset was 23.16%. The lowest was 6.11%. And the median was 17.69%.
NSE:PRAMODINI's Return-on-Tangible-Asset is ranked better than 66.72% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 2.61
vs NSE:PRAMODINI: 6.11
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Pramodini Medicare Return-on-Tangible-Asset Related Terms
Pramodini Medicare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare Return-on-Tangible-Asset Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Asset
9.05
14.42
20.96
23.16
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
Return-on-Tangible-Asset
0.00
0.00
0.00
0.00
21.42
NSE:PRAMODINI vs HCA, THC, EHC: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 21.42% mean?
Pramodini Medicare (NSE:PRAMODINI) has a Return-on-Tangible-Asset of 21.42% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pramodini Medicare and its competitors. This is 21% above median its historical median of 17.69. Over the past decade, Pramodini Medicare's Return-on-Tangible-Asset has ranged from 6.11 to 23.16. According to the industry distribution chart, Pramodini Medicare ranks #228 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 33.3%.
Is Pramodini Medicare's Return-on-Tangible-Asset too high?
Pramodini Medicare's current Return-on-Tangible-Asset of 21.42% is 21% above median its 10-year median of 17.69. Over the past 10 years, this metric has ranged from a low of 6.11 to a high of 23.16. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.61. Pramodini Medicare's value of 21.42% is 720.7% above this industry median. Based on the distribution chart, Pramodini Medicare ranks #228 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #228 out of 685 companies for Return-on-Tangible-Asset. This puts Pramodini Medicare in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.61. Pramodini Medicare's value of 21.42% is 720.7% above this benchmark. Historically, Pramodini Medicare's own Return-on-Tangible-Asset has ranged from 6.11 to 23.16 over the past decade. While the company's 10-year median is 17.69 vs. the industry median of 2.61, Pramodini Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.61, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pramodini Medicare's current Return-on-Tangible-Asset of 21.42% is 720.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current Return-on-Tangible-Asset is 21.42%, which is 21% above median its own 10-year median of 17.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Return-on-Tangible-Asset of 21.42%. The current Return-on-Tangible-Asset is 21.42%, which is 21% above median its 10-year median of 17.69 and 720.7% above the Healthcare Providers & Services industry median of 2.61. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Return-on-Tangible-Asset is 21.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
